Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia.

Blood neoplasia·2026
Same author

Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy.

Neuro-oncology advances·2026
Same author

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival.

Neuro-oncology·2025
Same author

PhoCoil: A photodegradable and injectable single-component recombinant protein hydrogel for minimally invasive delivery and degradation.

Science advances·2025
Same author

Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data.

Neuro-oncology advances·2025
Same author

Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy.

Nature cancer·2025

Related Experiment Video

Updated: May 26, 2026

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

In vivo bio-imaging using chlorotoxin-based conjugates.

Mark R Stroud1, Stacey J Hansen, James M Olson

  • 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Current Pharmaceutical Design
|December 30, 2011
PubMed
Summary
This summary is machine-generated.

Improved surgical cancer margin detection is crucial for patient outcomes. Research into chlorotoxin-targeted optical imaging agents aims to enhance tumor delineation during surgery, potentially reducing cancer recurrence and patient morbidity.

More Related Videos

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide
09:02

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

Published on: June 11, 2020

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Related Experiment Videos

Last Updated: May 26, 2026

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide
09:02

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

Published on: June 11, 2020

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Area of Science:

  • Oncology
  • Surgical Oncology
  • Biomedical Imaging

Background:

  • Surgical resection is the main cancer treatment.
  • Accurate tumor margin delineation is vital for successful surgery and patient prognosis.
  • Current methods for identifying tumor margins during surgery are often imprecise, leading to potential issues like tumor recurrence or unnecessary damage to healthy tissue.

Purpose of the Study:

  • To review the history and tumor specificity of chlorotoxin.
  • To discuss current research on developing optical imaging agents targeted to cancer tissue.
  • To explore how improved intra-operative margin identification can enhance cancer therapy and reduce patient morbidity.

Main Methods:

  • Literature review on chlorotoxin's properties and tumor specificity.
  • Analysis of ongoing research into targeted optical imaging agents for cancer.
  • Discussion of the potential impact of improved margin delineation tools in surgical oncology.

Main Results:

  • Chlorotoxin exhibits specificity for tumor tissue.
  • Research is advancing the development of optical imaging agents that can be directed to cancer cells.
  • Targeted optical imaging holds promise for improving the precision of tumor margin identification.

Conclusions:

  • Enhanced tools for distinguishing tumor margins are needed to improve surgical outcomes.
  • Chlorotoxin-based and other targeted optical imaging agents represent a promising avenue for improving intra-operative tumor delineation.
  • Advancements in this area could lead to reduced tumor progression and patient morbidity.